Related references
Note: Only part of the references are listed.Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl] phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent
Yoon T. Jeon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds
Rejean Ruel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents
Zulan Pi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility
Tammy C. Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Conformationally Constrained ortho-Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y1 Antagonist
Jennifer X. Qiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y1 Antagonists
Hannguang Chao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Virtual screening leads to the discovery of novel non-nucleotide P2Y1 receptor antagonists
Stefano Costanzi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis
J. Eileen Bird et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
Convergent Synthesis of the Potent P2Y Receptor Antagonist MG 50-3-1 Based on a Regioselective Ullmann Coupling Reaction
Younis Baqi et al.
MOLECULES (2012)
Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor
Mariano A. Giorgi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Transformation of Anionically Activated Trifluoromethyl Groups to Heterocycles under Mild Aqueous Conditions
Jennifer X. Qiao et al.
ORGANIC LETTERS (2011)
P2 receptors and platelet function
Baatrice Hechler et al.
PURINERGIC SIGNALLING (2011)
Pharmacochemistry of the platelet purinergic receptors
Kenneth A. Jacobson et al.
PURINERGIC SIGNALLING (2011)
Benzofuran-substituted urea derivatives as novel P2Y1 receptor antagonists
Reema K. Thalji et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis of Tertiary Amides from Anionically Activated Aromatic Trifluoromethyl Groups
Gavin O'Mahony et al.
ORGANIC LETTERS (2010)
Ticagrelor: The First Reversibly Binding Oral P2Y(12) Receptor Antagonist
Steen Husted et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Comparison of ticagrelor and thienopyridine P2Y12 binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis
J. J. J. van Giezen et al.
THROMBOSIS RESEARCH (2009)
Tetrahydro-4-quinolinamines identified as novel P2Y1 receptor antagonists
Angel I. Morales-Ramos et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
P2Y1 receptor antagonists as novel antithrombotic agents
Jeffrey A. Pfefferkorn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor
Dayle Houston et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
From ATP to AZD6140:: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis
Brian Springthorpe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats
William A. Schumacher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Biomarker optimization to track the antithrombotic and hemostatic effects of clopidogrel in rats
William A. Schumacher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans
Joseph A. Jakubowski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Development and validation of a platelet calcium flux assay using a fluorescent imaging plate reader
Eddie C. -K. Liu et al.
ANALYTICAL BIOCHEMISTRY (2006)
ADP receptors: Inhibitory strategies for antiplatelet therapy
Marco Cattaneo
DRUG NEWS & PERSPECTIVES (2006)
The role of ADP receptors in platelet function
S Murugappan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
The platelet P2 receptors in arterial thrombosis
C Gachet et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
MRS2500 [2-Iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice
B Hechler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The platelet ATP and ADP receptors
C Oury et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Potential energy functions for atomic-level simulations of water and organic and biomolecular systems
WL Jorgensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The P2 receptors in platelet function
B Hechler et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist
N Lenain et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist
A Baurand et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Share Paper
